PHARMACOTHERAPEUTICS FOR
ADVANCED
PRACTICE NURSE
PRESCRIBERS, 6TH EDITION BY
WOO & WRIGHT.
Chapter 1 to chapter 57
Contents
CHAPTER 1: THE ROLE OF THE ADVANCED PRACTICE NURSE AS
PRESCRIBER .... 4
CHAPTER 2. REVIEW OF BASIC PRINCIPLES OF
PHARMACOLOGY ........................ 6
CHAPTER 3. RATIONAL DRUG
SELECTION ............................................................ 18
CHAPTER 4. LEGAL AND PROFESSIONAL ISSUES IN
PRESCRIBING .................... 22
CHAPTER 5. ADVERSE DRUG
REACTIONS ............................................................. 26
CHAPTER 6. AN INTRODUCTION TO
PHARMACOGENOMICS ................................ 32
CHAPTER 7. NUTRITION AND
NUTRACEUTICALS ................................................. 36
CHAPTER 8. HERBAL
THERAPIES........................................................................... 48
CHAPTER 9.
CANNABIS ..........................................................................................
55
, lOMoARcPSD|27916040
CHAPTER 10.
PHARMACOECONOMICS .................................................................. 64
CHAPTER 11. DRUGS AFFECTING THE AUTONOMIC NERVOUS
SYSTEM .............. 69
CHAPTER 12. DRUGS AFFECTING THE CENTRAL NERVOUS
SYSTEM .................... 84
CHAPTER 13: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL
SYSTEMS
..............................................................................................................
.................. ..........99
CHAPTER 14: DRUGS AFFECTING THE RESPIRATORY
SYSTEM .......................... 116
CHAPTER 15: DRUGS AFFECTING THE HEMATOLOGICAL
SYSTEM ..................... 125
CHAPTER 16: DRUGS AFFECTING THE IMMUNE SYSTEM (VACCINES &
IMMUNOGLOBULINS) ..............................................................................
............ 133
CHAPTER 17. DRUGS AFFECTING THE IMMUNE SYSTEM:
IMMUNOMODULATORS
..............................................................................................................
.................. ........144
CHAPTER 18. DRUGS AFFECTING THE GASTROINTESTINAL
SYSTEM ................ 147
CHAPTER 19. DRUGS AFFECTING THE ENDOCRINE SYSTEM: PANCREATIC
HORMONES & ANTIDIABETIC
DRUGS ................................................................. 152
CHAPTER 20. DRUGS AFFECTING THE ENDOCRINE SYSTEM: PITUITARY,
THYROID,
& ADRENAL
DRUGS ..............................................................................................
159
CHAPTER 21. DRUGS AFFECTING THE REPRODUCTIVE
SYSTEM........................ 163
CHAPTER 22: DRUGS AFFECTING THE BONES AND
JOINTS ............................... 174
CHAPTER 23: DRUGS AFFECTING THE INTEGUMENTARY
SYSTEM ..................... 183
CHAPTER 24: DRUGS USED TO TREAT BACTERIAL
INFECTIONS ........................ 192
CHAPTER 25: DRUGS USED TO TREAT VIRAL, FUNGAL, AND PROTOZOAL
INFECTIONS ...........................................................................................
.............. 200
CHAPTER 26: DRUGS USED TO TREAT INFLAMMATORY
PROCESSES ................. 205 CHAPTER 27. DRUGS USED TO TREAT EYE
AND EAR DISORDERS ...................... 211
,CHAPTER 28.
ANEMIA .......................................................................................... 216
CHAPTER 29. ANXIETY AND
DEPRESSION .......................................................... 222
CHAPTER 30. ATTENTION DEFICIT-HYPERACTIVITY
DISORDER ....................... 230
CHAPTER 31. ASTHMA AND
ALLERGY .................................................................. 234
CHAPTER 32. CHRONIC OBSTRUCTIVE PULMONARY
DISEASE .......................... 241
CHAPTER 33.
CONTRACEPTION ........................................................................... 245
CHAPTER 34. COVID-19: ACUTE AND
CHRONIC ................................................. 251
CHAPTER 35. DERMATOLOGICAL
CONDITIONS .................................................. 259
CHAPTER 36. DIABETES
MANAGEMENT .............................................................. 266
CHAPTER 37: GASTROESOPHAGEAL REFLUX AND PEPTIC ULCER
DISEASE ...... 281
CHAPTER 38:
HEADACHES ................................................................................... 287
CHAPTER 39: HEART
FAILURE ................................................................................... 293
CHAPTER 40: HIV AND
AIDS ................................................................................ 302
CHAPTER 41: MENOPAUSAL HORMONE
THERAPY .............................................. 309
CHAPTER 42:
HYPERLIPIDEMIA ......................................................................... 314
CHAPTER 43:
HYPERTENSION ............................................................................. 323
CHAPTER 45.
OBESITY ......................................................................................... 339
CHAPTER 46. PAIN MANAGEMENT: ACUTE AND CHRONIC
PAIN ........................ 348
CHAPTER 47.
PNEUMONIA .................................................................................. 355
CHAPTER 48. SEXUALLY TRANSMITTED DISEASES AND
VAGINITIS ................... 359
CHAPTER 49. SUBSTANCE USE
DISORDERS ........................................................ 366
CHAPTER 50:
TUBERCULOSIS ............................................................................. 376
, lOMoARcPSD|27916040
CHAPTER 51: UPPER RESPIRATORY TRACT INFECTIONS (URI,
PHARYNGITIS,
SINUSITIS,
OTITIS) .............................................................................................
381
CHAPTER 52: URINARY TRACT
INFECTIONS ...................................................... 387
CHAPTER 53: WOMEN AS
PATIENTS ......................................................................... 392
CHAPTER 54: MEN AS
PATIENTS ............................................................................... 400
CHAPTER 55: PEDIATRIC
PATIENTS ......................................................................... 404
CHAPTER 56: TRANSGENDER
CLIENTS ............................................................... 408
CHAPTER 57: GERIATRIC
PATIENTS ......................................................................... 413
CHAPTER 1: THE ROLE OF THE ADVANCED PRACTICE NURSE AS
PRESCRIBER
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D.The State Board of Pharmacy
Answer: C
Rationale: Prescriptive authority for nurse practitioners (NPs) is
determined by state laws and regulations enacted by each
state’s Board of Nursing (or the combined Board of
Nursing/Medicine in some jurisdictions). Federal bodies, such as
the DEA, regulate controlled substances, but do not grant or
define NP authority to prescribe.
ADVANCED
PRACTICE NURSE
PRESCRIBERS, 6TH EDITION BY
WOO & WRIGHT.
Chapter 1 to chapter 57
Contents
CHAPTER 1: THE ROLE OF THE ADVANCED PRACTICE NURSE AS
PRESCRIBER .... 4
CHAPTER 2. REVIEW OF BASIC PRINCIPLES OF
PHARMACOLOGY ........................ 6
CHAPTER 3. RATIONAL DRUG
SELECTION ............................................................ 18
CHAPTER 4. LEGAL AND PROFESSIONAL ISSUES IN
PRESCRIBING .................... 22
CHAPTER 5. ADVERSE DRUG
REACTIONS ............................................................. 26
CHAPTER 6. AN INTRODUCTION TO
PHARMACOGENOMICS ................................ 32
CHAPTER 7. NUTRITION AND
NUTRACEUTICALS ................................................. 36
CHAPTER 8. HERBAL
THERAPIES........................................................................... 48
CHAPTER 9.
CANNABIS ..........................................................................................
55
, lOMoARcPSD|27916040
CHAPTER 10.
PHARMACOECONOMICS .................................................................. 64
CHAPTER 11. DRUGS AFFECTING THE AUTONOMIC NERVOUS
SYSTEM .............. 69
CHAPTER 12. DRUGS AFFECTING THE CENTRAL NERVOUS
SYSTEM .................... 84
CHAPTER 13: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL
SYSTEMS
..............................................................................................................
.................. ..........99
CHAPTER 14: DRUGS AFFECTING THE RESPIRATORY
SYSTEM .......................... 116
CHAPTER 15: DRUGS AFFECTING THE HEMATOLOGICAL
SYSTEM ..................... 125
CHAPTER 16: DRUGS AFFECTING THE IMMUNE SYSTEM (VACCINES &
IMMUNOGLOBULINS) ..............................................................................
............ 133
CHAPTER 17. DRUGS AFFECTING THE IMMUNE SYSTEM:
IMMUNOMODULATORS
..............................................................................................................
.................. ........144
CHAPTER 18. DRUGS AFFECTING THE GASTROINTESTINAL
SYSTEM ................ 147
CHAPTER 19. DRUGS AFFECTING THE ENDOCRINE SYSTEM: PANCREATIC
HORMONES & ANTIDIABETIC
DRUGS ................................................................. 152
CHAPTER 20. DRUGS AFFECTING THE ENDOCRINE SYSTEM: PITUITARY,
THYROID,
& ADRENAL
DRUGS ..............................................................................................
159
CHAPTER 21. DRUGS AFFECTING THE REPRODUCTIVE
SYSTEM........................ 163
CHAPTER 22: DRUGS AFFECTING THE BONES AND
JOINTS ............................... 174
CHAPTER 23: DRUGS AFFECTING THE INTEGUMENTARY
SYSTEM ..................... 183
CHAPTER 24: DRUGS USED TO TREAT BACTERIAL
INFECTIONS ........................ 192
CHAPTER 25: DRUGS USED TO TREAT VIRAL, FUNGAL, AND PROTOZOAL
INFECTIONS ...........................................................................................
.............. 200
CHAPTER 26: DRUGS USED TO TREAT INFLAMMATORY
PROCESSES ................. 205 CHAPTER 27. DRUGS USED TO TREAT EYE
AND EAR DISORDERS ...................... 211
,CHAPTER 28.
ANEMIA .......................................................................................... 216
CHAPTER 29. ANXIETY AND
DEPRESSION .......................................................... 222
CHAPTER 30. ATTENTION DEFICIT-HYPERACTIVITY
DISORDER ....................... 230
CHAPTER 31. ASTHMA AND
ALLERGY .................................................................. 234
CHAPTER 32. CHRONIC OBSTRUCTIVE PULMONARY
DISEASE .......................... 241
CHAPTER 33.
CONTRACEPTION ........................................................................... 245
CHAPTER 34. COVID-19: ACUTE AND
CHRONIC ................................................. 251
CHAPTER 35. DERMATOLOGICAL
CONDITIONS .................................................. 259
CHAPTER 36. DIABETES
MANAGEMENT .............................................................. 266
CHAPTER 37: GASTROESOPHAGEAL REFLUX AND PEPTIC ULCER
DISEASE ...... 281
CHAPTER 38:
HEADACHES ................................................................................... 287
CHAPTER 39: HEART
FAILURE ................................................................................... 293
CHAPTER 40: HIV AND
AIDS ................................................................................ 302
CHAPTER 41: MENOPAUSAL HORMONE
THERAPY .............................................. 309
CHAPTER 42:
HYPERLIPIDEMIA ......................................................................... 314
CHAPTER 43:
HYPERTENSION ............................................................................. 323
CHAPTER 45.
OBESITY ......................................................................................... 339
CHAPTER 46. PAIN MANAGEMENT: ACUTE AND CHRONIC
PAIN ........................ 348
CHAPTER 47.
PNEUMONIA .................................................................................. 355
CHAPTER 48. SEXUALLY TRANSMITTED DISEASES AND
VAGINITIS ................... 359
CHAPTER 49. SUBSTANCE USE
DISORDERS ........................................................ 366
CHAPTER 50:
TUBERCULOSIS ............................................................................. 376
, lOMoARcPSD|27916040
CHAPTER 51: UPPER RESPIRATORY TRACT INFECTIONS (URI,
PHARYNGITIS,
SINUSITIS,
OTITIS) .............................................................................................
381
CHAPTER 52: URINARY TRACT
INFECTIONS ...................................................... 387
CHAPTER 53: WOMEN AS
PATIENTS ......................................................................... 392
CHAPTER 54: MEN AS
PATIENTS ............................................................................... 400
CHAPTER 55: PEDIATRIC
PATIENTS ......................................................................... 404
CHAPTER 56: TRANSGENDER
CLIENTS ............................................................... 408
CHAPTER 57: GERIATRIC
PATIENTS ......................................................................... 413
CHAPTER 1: THE ROLE OF THE ADVANCED PRACTICE NURSE AS
PRESCRIBER
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D.The State Board of Pharmacy
Answer: C
Rationale: Prescriptive authority for nurse practitioners (NPs) is
determined by state laws and regulations enacted by each
state’s Board of Nursing (or the combined Board of
Nursing/Medicine in some jurisdictions). Federal bodies, such as
the DEA, regulate controlled substances, but do not grant or
define NP authority to prescribe.
